A comprehensive view of health care, pharmaceuticals & wellness. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
BIOGEN INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 24, 2024
by SEC Edgar Filings
|
UNITEDHEALTH GROUP INC - (8-K/A) - Disclosing
Published:
April 24, 2024
by SEC Edgar Filings
|
GlobalData: Success of mRNA vaccine technology during Covid-19 pandemic could lead to using platform to reduce preventable illness across multiple disease areas; about 507 preventive vaccines in late-stage development, with 88 using mRNA technology
Published:
April 24, 2024
by Indo-Asian News Service
|
Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published:
April 24, 2024
by CE Noticias Financieras (Latin America)
|
ANGLE partners with AstraZeneca to enhance cancer drug development using DNA damage response assay; companies to adapt ANGLE's existing Parsortix-based assay for identifying micronuclei in circulating tumor cells
Published:
April 24, 2024
by Proactive Investors
|
Ask us about our Health Care Sector market view